These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34119057)

  • 1. A strategy for SARS-CoV-2 vaccination in Yemen.
    Nasser A; Zakham F
    Lancet; 2021 Jun; 397(10291):2247. PubMed ID: 34119057
    [No Abstract]   [Full Text] [Related]  

  • 2. The Impact of Armed Conflict on the Epidemiological Situation of COVID-19 in Libya, Syria and Yemen.
    Daw MA
    Front Public Health; 2021; 9():667364. PubMed ID: 34178925
    [No Abstract]   [Full Text] [Related]  

  • 3. Fears of "highly catastrophic" COVID-19 spread in Yemen.
    Devi S
    Lancet; 2020 May; 395(10238):1683. PubMed ID: 32473668
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical care for COVID-19 during a humanitarian crisis-lessons learnt from Yemen.
    Lee JS; Godard A
    Crit Care; 2020 Sep; 24(1):572. PubMed ID: 32972450
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19: Is herd immunity the only option for fragile Yemen?
    Noushad M; Al-Saqqaf IS
    Int J Infect Dis; 2021 May; 106():79-82. PubMed ID: 33737135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?
    Valderrama-Beltrán S; Cuervo-Rojas J; Martinez-Vernaza S; Alvarez-Moreno CA; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2023; 56():102650. PubMed ID: 37813321
    [No Abstract]   [Full Text] [Related]  

  • 7. Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers.
    Wang W; Balfe P; Eyre DW; Lumley SF; O'Donnell D; Warren F; Crook DW; Jeffery K; Matthews PC; Klerman EB; McKeating JA
    J Biol Rhythms; 2022 Feb; 37(1):124-129. PubMed ID: 34866459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and vaccination: myths vs science.
    Chavda VP; Chen Y; Dave J; Chen ZS; Chauhan SC; Yallapu MM; Uversky VN; Bezbaruah R; Patel S; Apostolopoulos V
    Expert Rev Vaccines; 2022 Nov; 21(11):1603-1620. PubMed ID: 35980281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Vaccination during the COVID-19 pandemic.
    Danchin M
    Aust J Gen Pract; 2020 Oct; 49(10):621. PubMed ID: 33015675
    [No Abstract]   [Full Text] [Related]  

  • 11. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
    Khade SM; Yabaji SM; Srivastava J
    Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic on the utilisation of health services at public hospitals in Yemen: a retrospective comparative study.
    Kotiso M; Qirbi N; Al-Shabi K; Vuolo E; Al-Waleedi A; Naiene J; Senga M; Khalil M; Basaleem H; Alhidary A
    BMJ Open; 2022 Jan; 12(1):e047868. PubMed ID: 34980605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies and safety considerations of booster vaccination in COVID-19.
    Meng H; Mao J; Ye Q
    Bosn J Basic Med Sci; 2022 Jun; 22(3):366-373. PubMed ID: 35366790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination for SARS-CoV-2 of migrants and refugees, Jordan.
    Bellizzi S; Aidyralieva C; Alsawhala L; Al-Shaikh A; Santoro A; Profili MC
    Bull World Health Organ; 2021 Sep; 99(9):611. PubMed ID: 34475595
    [No Abstract]   [Full Text] [Related]  

  • 15. A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
    Neuhann JM; Stemler J; Carcas A; Frías-Iniesta J; Bethe U; Heringer S; Tischmann L; Zarrouk M; Cüppers A; König F; Posch M; Cornely OA
    Trials; 2022 Oct; 23(1):865. PubMed ID: 36209129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field Epidemiology Training Program Response to COVID-19 During a Conflict: Experience From Yemen.
    Al Serouri AA; Ghaleb YA; Al Aghbari LA; Al Amad MA; Alkohlani AS; Almoayed KA; Jumaan AO
    Front Public Health; 2021; 9():688119. PubMed ID: 34881214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 seroprevalence in Aden, Yemen: a population-based study.
    Bin-Ghouth AS; Al-Shoteri S; Mahmoud N; Musani A; Baoom NM; Al-Waleedi AA; Buliva E; Aly EA; Naiene JD; Crestani R; Senga M; Barakat A; Al-Ariqi L; Al-Sakkaf KZ; Shaef A; Thabit N; Murshed A; Omara S
    Int J Infect Dis; 2022 Feb; 115():239-244. PubMed ID: 34929358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
    Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
    EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
    [No Abstract]   [Full Text] [Related]  

  • 20. Spotlight on Vaccines: Pandemic May Open Gateway to Improve Vaccination Rates in Texas.
    Price S
    Tex Med; 2021 Mar; 117(3):20-25. PubMed ID: 34855954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.